Literature DB >> 22778103

Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection.

Wei-Jen Chua1, Steven M Truscott, Christopher S Eickhoff, Azra Blazevic, Daniel F Hoft, Ted H Hansen.   

Abstract

Mucosa-associated invariant T (MAIT) cells are a unique population of αβ T cells in mammals that reside preferentially in mucosal tissues and express an invariant Vα paired with limited Vβ T-cell receptor (TCR) chains. Furthermore, MAIT cell development is dependent upon the expression of the evolutionarily conserved major histocompatibility complex (MHC) class Ib molecule MR1. Using in vitro assays, recent studies have shown that mouse and human MAIT cells are activated by antigen-presenting cells (APCs) infected with diverse microbes, including numerous bacterial strains and yeasts, but not viral pathogens. However, whether MAIT cells play an important, and perhaps unique, role in controlling microbial infection has remained unclear. To probe MAIT cell function, we show here that purified polyclonal MAIT cells potently inhibit intracellular bacterial growth of Mycobacterium bovis BCG in macrophages (MΦ) in coculture assays, and this inhibitory activity was dependent upon MAIT cell selection by MR1, secretion of gamma interferon (IFN-γ), and an innate interleukin 12 (IL-12) signal from infected MΦ. Surprisingly, however, the cognate recognition of MR1 by MAIT cells on the infected MΦ was found to play only a minor role in MAIT cell effector function. We also report that MAIT cell-deficient mice had higher bacterial loads at early times after infection compared to wild-type (WT) mice, demonstrating that MAIT cells play a unique role among innate lymphocytes in protective immunity against bacterial infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22778103      PMCID: PMC3418730          DOI: 10.1128/IAI.00279-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  80 in total

1.  Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties.

Authors:  Eva Billerbeck; Yu-Hoi Kang; Lucy Walker; Helen Lockstone; Stefanie Grafmueller; Vicki Fleming; Jonathan Flint; Chris B Willberg; Bertram Bengsch; Bianca Seigel; Narayan Ramamurthy; Nicole Zitzmann; Eleanor J Barnes; Jonarthan Thevanayagam; Anisha Bhagwanani; Alasdair Leslie; Ye H Oo; Simon Kollnberger; Paul Bowness; Oliver Drognitz; David H Adams; Hubert E Blum; Robert Thimme; Paul Klenerman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-28       Impact factor: 11.205

2.  Beta2-microglobulin-dependent bacterial clearance and survival during murine Klebsiella pneumoniae bacteremia.

Authors:  Anna L Cogen; Thomas A Moore
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

3.  Development of a murine mycobacterial growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosis.

Authors:  Marcela Parra; Amy L Yang; JaeHyun Lim; Kristopher Kolibab; Steven Derrick; Nathalie Cadieux; Liyanage P Perera; William R Jacobs; Michael Brennan; Sheldon L Morris
Journal:  Clin Vaccine Immunol       Date:  2009-05-20

4.  Mousepox in the C57BL/6 strain provides an improved model for evaluating anti-poxvirus therapies.

Authors:  Scott Parker; Akbar M Siddiqui; Christina Oberle; Ed Hembrador; Randall Lanier; George Painter; Alice Robertson; R Mark Buller
Journal:  Virology       Date:  2008-12-18       Impact factor: 3.616

5.  Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis.

Authors:  Yinyao Lin; Shane Ritchea; Alison Logar; Samantha Slight; Michelle Messmer; Javier Rangel-Moreno; Lokesh Guglani; John F Alcorn; Heather Strawbridge; Sang Mi Park; Reiko Onishi; Nikki Nyugen; Michael J Walter; Derek Pociask; Troy D Randall; Sarah L Gaffen; Yoichiro Iwakura; Jay K Kolls; Shabaana A Khader
Journal:  Immunity       Date:  2009-10-22       Impact factor: 31.745

Review 6.  Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens.

Authors:  Meredith M Curtis; Sing Sing Way
Journal:  Immunology       Date:  2009-02       Impact factor: 7.397

7.  MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution.

Authors:  Shouxiong Huang; Emmanuel Martin; Sojung Kim; Lawrence Yu; Claire Soudais; Daved H Fremont; Olivier Lantz; Ted H Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-30       Impact factor: 11.205

Review 8.  Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.

Authors:  Shen-Ying Zhang; Stéphanie Boisson-Dupuis; Ariane Chapgier; Kun Yang; Jacinta Bustamante; Anne Puel; Capucine Picard; Laurent Abel; Emmanuelle Jouanguy; Jean-Laurent Casanova
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

Review 9.  The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis.

Authors:  Andrea M Cooper; Shabaana A Khader
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

10.  Stepwise development of MAIT cells in mouse and human.

Authors:  Emmanuel Martin; Emmanuel Treiner; Livine Duban; Lucia Guerri; Hélène Laude; Cécile Toly; Virginie Premel; Anne Devys; Ivan C Moura; Florence Tilloy; Stéphane Cherif; Gabriella Vera; Sylvain Latour; Claire Soudais; Olivier Lantz
Journal:  PLoS Biol       Date:  2009-03-10       Impact factor: 8.029

View more
  133 in total

1.  Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines.

Authors:  Joana Dias; Edwin Leeansyah; Johan K Sandberg
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

Review 2.  The role of mucosal-associated invariant T cells in infectious diseases.

Authors:  Emily B Wong; Thumbi Ndung'u; Victoria O Kasprowicz
Journal:  Immunology       Date:  2016-10-26       Impact factor: 7.397

3.  Recipient mucosal-associated invariant T cells control GVHD within the colon.

Authors:  Antiopi Varelias; Mark D Bunting; Kate L Ormerod; Motoko Koyama; Stuart D Olver; Jasmin Straube; Rachel D Kuns; Renee J Robb; Andrea S Henden; Leanne Cooper; Nancy Lachner; Kate H Gartlan; Olivier Lantz; Lars Kjer-Nielsen; Jeffrey Yw Mak; David P Fairlie; Andrew D Clouston; James McCluskey; Jamie Rossjohn; Steven W Lane; Philip Hugenholtz; Geoffrey R Hill
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

Review 4.  Early clearance of Mycobacterium tuberculosis: a new frontier in prevention.

Authors:  Ayesha J Verrall; Mihai G Netea; Bachti Alisjahbana; Philip C Hill; Reimout van Crevel
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

Review 5.  Killing Mycobacterium tuberculosis In Vitro: What Model Systems Can Teach Us.

Authors:  Tracy L Keiser; Georgiana E Purdy
Journal:  Microbiol Spectr       Date:  2017-06

6.  Mucosal associated invariant T cells: don't forget your vitamins.

Authors:  Mary H Young; Laurent Gapin
Journal:  Cell Res       Date:  2012-12-04       Impact factor: 25.617

Review 7.  Co-dependents: MR1-restricted MAIT cells and their antimicrobial function.

Authors:  Marielle C Gold; David M Lewinsohn
Journal:  Nat Rev Microbiol       Date:  2012-11-26       Impact factor: 60.633

8.  Immunology: Vitamins prime immunity.

Authors:  Wei-Jen Chua; Ted H Hansen
Journal:  Nature       Date:  2012-11-29       Impact factor: 49.962

9.  Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection.

Authors:  Edwin Leeansyah; Anupama Ganesh; Máire F Quigley; Anders Sönnerborg; Jan Andersson; Peter W Hunt; Ma Somsouk; Steven G Deeks; Jeffrey N Martin; Markus Moll; Barbara L Shacklett; Johan K Sandberg
Journal:  Blood       Date:  2012-12-13       Impact factor: 22.113

Review 10.  MAIT cells and pathogen defense.

Authors:  Siobhán C Cowley
Journal:  Cell Mol Life Sci       Date:  2014-08-28       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.